Sequenom Announces Participation At The Barclays Global Healthcare Conference

Sequenom Announces Participation At The Barclays Global Healthcare Conference

PR Newswire

SAN DIEGO, March 5, 2013

SAN DIEGO, March 5, 2013 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative diagnostic testing and genetic analysis
solutions, today announced the Company's participation at the Barclays Global
Healthcare Conference at the Loews Miami Hotel in Miami, FL on March 12-14,

Ronald M. Lindsay, Ph.D., Director and EVP of Strategic Planning, will present
on Wednesday, March 13, 2013, beginning at 4:45 p.m. ET, to provide an
overview of and update on the Company. The presentation is expected to last
approximately 25 minutes and will be web cast live through the "Investors"
section of the Sequenom website at An audio replay will be
available for 30 days following the initial presentation web cast.

About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a Web site at to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
Web site to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the Web site.


SOURCE Sequenom, Inc.

Contact: Marcy Graham, Senior Director, Investor Relations & Corp Comm,
Sequenom, Inc., 1-858-202-9028,; Jakob Jakobsen, Media
Contact, Chandler Chicco Agency, +1-310-309-1003,
Press spacebar to pause and continue. Press esc to stop.